Disclosures. Nothing Medically I own FiPhysician LLC, a financial planning and investment company (FiPhysician.com)
|
|
- Colin Greene
- 5 years ago
- Views:
Transcription
1 "How to work around (with) administration to build an Antimicrobial Stewardship Program AND how to get dumb (oops reluctant) doctors to do the right thing" David Graham, MD
2 Disclosures Nothing Medically I own FiPhysician LLC, a financial planning and investment company (FiPhysician.com) 2
3 Objectives Try and start an AMS program that will build administrative support Learn how doctors think (or don t think) about antibiotics Discuss what interventions might work to decrease antibiotic use 3
4 How I got my start I just started. I didn t ask permission or try to get funding A year later, after our system supported AMS, I went in front of the QPSC to pitch for pharmacy support Program continued to grow with ID trained pharmacist 4
5 Slides from my talk 5
6 Additional slides in support 6
7 Summary slide from presentation A formal ASP program is supported by SCLHS and in the works Managed by pharmacy 1 FTE ASP pharmacist to run the program hopefully August 1 st Low hanging fruit still to be harvested IV to PO Review all antibiotics at 72 hours Need to focus on carbapenems Discussion on FTE for physician leadership Opportunity to leverage technology and make it regional
8 Posted in the ED Please DON T give antibiotics if: 1. You suspect endocarditis. Endocarditis is a diagnostic emergency, not an antibiotic emergency. Standard of care is 3 sets of blood cultures in 24 hours (or in 8 hours if they are ill) PRIOR to giving antibiotics. (from UpToDate: Blood cultures should be obtained prior to initiation of antibiotic therapy. At least three sets of blood cultures should be obtained; in patients who have received recent antimicrobial therapy, additional blood cultures may be useful. If the tempo of illness is subacute and the patient is not critically ill, it is reasonable to delay initiation of antimicrobial therapy while awaiting the results of blood cultures and other diagnostic tests. In the setting of acute illness, three sets of blood cultures should be obtained over a one-hour period prior to initiation of empiric antimicrobial therapy.) 2. You suspect discitis. Blood cultures are often helpful in diagnosis. If they are not, we use CT guided biopsy to attempt to get a culture. No empiric antibiotics prior to CT guided biopsy. (If they have epidural abscess with neurological changes, or going straight to OR or ICU, then yes give antibiotics) 3. You suspect septic joint. Aspiration prior to empiric antibiotics 4. You suspect joint arthroplasty infection. Hold antibiotics until surgery. Notes on Surviving Sepsis (SS) and CMS s SEP 1 rule: For those with SEVERE sepsis or Septic SHOCK: SS suggests antibiotics in less than an hour and SEP 1 in less than 3 hours. Most folks with the above conditions will just have sepsis or not even meet those criteria. From my perspective diagnosis is much more important than antibiotics unless they are very ill. 8
9 Bugs and Drugs Digest Volume 1 A cellulitis question: can you tell just by looking if MRSA is likely or not? YES if there is purulence, it could be MRSA. If there is no purulence, it is not MRSA. Reference: Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America. CID. 10:1098 Please don t use vanco for nonpurulent infections, which are usually strep. Vanco is an old-fashioned poorly effective (crap) drug that we started using again because we had no alternatives, and we didn t know that MRSA doesn t cause nonpurulent infections. We have much more effective and safer antibiotics such as keflex or clinda by mouth, or ancef or clinda IV. Ceftriaxone can be given once in the ED or daily in the infusion center and will be much more effective than vanco. 9
10 From Infectious Diseases Society of America Skin and Soft Tissue Infection Guidelines or google: idsa skin and soft tissue infection guidelines Notes: 1. If there is pus (Purulent) then I & D is necessary and cover for MRSA if moderate or severe 2. If there is NOT PUS (non purulent) then you do not need to cover for MRSA. Consider ancef or ancef/clinda if it looks bad. Or ceftriaxone 2gm/day. 3. Only if the nonpurulent infection is severe (in the ICU and calling general surgery to debride) do you need vanco/zosyn. 10
11 C. diff update for 2017 Attention will be paid to the culture around C. diff diagnosis and treatment in Hospital acquired C. diff is a Ministerial Excellence Goal for SCL this year, and not coincidentally, it will also be nationally reportable through CMS. We now understand that PCR testing over-diagnoses C. diff! Those who are colonized with C. diff are often falsely diagnosed and treated for C diff associated diarrhea (CDAD). Remember, to meet criteria for CDAD, you need to have 3 episodes of diarrhea in 24 hours. If there is just a single loose stool or episode of diarrhea, patients do not have CDAD even if they have a positive PCR for C. diff. In effort to decrease diagnosis of C. diff colonization, the lab will change its assay for C. diff in Testing will be for GDH and Toxin antigens. If both are positive, the result is positive. If bother are negative, the result is negative. If there are discordant responses, it will reflex to PCR for testing. Other things to remember: 1. We are not dinged for community onset C. diff, just hospital acquired C. diff (so please test for C. diff before 72 hours). 2. If someone presents with diarrhea, then acute testing with the GI multiplex PCR may be appropriate. If they have been in the hospital for a few days, the GI multiplex PCR is almost never appropriate (because it is expensive, and picks up mostly community associated causes of diarrhea, and will have the same issues with false positive C. diff PCRs). 3. Please try not to send any stool samples if someone has been on laxatives in the past hours. Remember stopping antibiotics will often get rid of diarrhea (even if it is due to C. diff!) and may be the thing to do rather than testing for C. diff and continuing unneeded antibiotics. 4. We will be encouraging nursing NOT to call a physician after a single episode of diarrhea and directly asking for a C. dif test. While the nursing sniff test is rather sensitive for C. diff, it is not specific and testing after a single loose stool is usually not appropriate. Thanks. We have learned a lot about C. diff in the last few years and it is actually a rather complicated disease. I look forward to working though diagnosis and treatment of C. diff this year with everyone. David Graham, MD Infectious Disease and director of Infection Control and Antimicrobial Stewardship 11
12 Empiric Antibiotics: How to Kill Montana Bugs Sepsis must give broad spectrum (vancomycin or cefazolin alone do not count). Ceftriaxone, ampicillin/sulbactam, IV levofloxacin, etc are all broad spectrum (Must have reliable strep, staph, and e. coli coverage per CMS). Skin Infection Abscess Inpatient Outpatient No Abscess Inpatient Outpatient UTI CAP Inpatient Outpatient Inpatient Outpatient HCAP HAP Abdominal Inpatient Outpatient Drain! culture if moderate or worse Vancomycin Bactrim, Doxycycline Cefazolin, Nafcillin, Clinda (IV Ceftriaxone or Unasyn if Septic ) Cephalexin Ceftriaxone Cefuroxime, Cephalexin, Bactrim, Macrobid (cystitis only), Cipro Ceftriaxone + Azithromycin PCN Allergic: Ceftriaxone + Azithromycin Cephalosporin Allergic: IV Levofloxacin 500mg Amox, Cephalexin, Cefuroxime, Augmentin, Azithro, Doxy, Levo No longer exists, see CAP above In Montana ceftriaxone + azithro is great Consider Vanco in necrotizing PNA or known MRSA colonization Consider Antipseudomonal if IV Antibiotics in previous 90 days or critically ill Double gram negative coverage is unnecessary in Montana. Ceftriaxone + PO metronidazole PCN Allergic: Ceftriaxone + PO Metronidazole Cephalosporin Allergic: Levo + PO Metronidazole or Ertapenem Ceftin + Metronidazole, Bactrim + Metronidazole, Levo + Metronidazole, Moxi (Augmentin and Unasyn poor options if concern for E. coli) Diabetic Foot Ceftriaxone + PO metronidazole, ampicillin/sulbactam No need to cover MRSA or Pseudomonas unless patient critically ill ***as a special reminder please remember for Meningitis the CSF PCR has revolutionized our care. If someone is sick and has meningitis, do blood work (including blood cultures) then give ceftriaxone 2gm stat. The PCR (meningitis encephalitis panel on EPIC) will be positive even after antibiotics. You can then get CT (if needed) and then LP. Consider steroids/vanco if you suspect pneumococcus, add acyclovir if you think it is HSV-1, add ampicillin if you think it is listeria. Your ID team is happy to answer questions M-F (and off hours if you are kind) David Graham zipit or (text if able) Jeff Jansen zipit or
13 Empiric OUTPATIENT Antibiotics: How to Kill Montana Bugs Skin Infection Abscess Drain! culture if moderate or worse Bactrim 2 DS BID OR Doxycycline 100mg BID 5 to 7 days UTI CAP No Abscess Cephalexin 1g TID Cefuroxime 500mg BID OR Cephalexin 1g BID Bactrim 1 DS BID Macrobid 100mg BID Amoxicillin 1g TID OR Azithromycin 500mg x1 then 250mg QD x4 OR Doxycycline 100mg BID 5 to 7 days 5 to 7 days 5 days 7 days 7 days 5 days 5 to 7 days If complicated or comorbid conditions: Cefuroxime 500mg BID PLUS Azithromycin 500mg x1 then 250mg QD x4 7 days 5 days COPD (C) Bronchitis (B) Sinusitis (S) Pharyngitis Abdominal PCN Allergy: Cefuroxime + Azithromycin Ceph Allergy: Levofloxacin 500mg QD *Not an antibiotic requiring vast majority of time* C,B: Azithromycin 500mg QD C,B,S: Doxycycline 100mg BID S: Amoxicillin 500mg BID or cefuroxime 250mg BID *Antibiotics only if Group A Strep positive* Amoxicillin 500mg BID PCN Allergy: Cefuroxime 250mg BID Ceph Allergy: Azithromycin 500mg x1 then 250mg QD x4 Cefuroxime 500mg BID PLUS Metronidazole 500mg TID As above 7 days 3 to 5 days 5 to 7 days 5 to 7 days 10 days 5 days 5 days 5 to 7 days 5 to 7 days PCN Allergy: Cefuroxime + Metronidazole Ceph Allergy: Levofloxacin 500mg QD PLUS Metronidazole 500mg TID As above 5 to 7 days Diabetic Foot and Animal Bites *Amoxicillin/clavulanic acid 875/125mg BID is a potential alternative therapy option but has poor susceptibility to e. coli (65% at baseline) *Diverticulitis does not require antimicrobial therapy if patient does not have a fever or leukocytosis [AVOD and DIOBOLO Trials]. Amoxicillin/Clavulanic Acid 875/125mg BID Cefuroxime 500mg BID PLUS Metronidazole 500mg TID 5 to 7 days, recommend close follow up if used empirically 7 to 14 days 7 to 14 days PCN Allergy: Cefuroxime + Metronidazole Ceph Allergy: Levofloxacin 500mg QD PLUS Metronidazole 500mg TID *These infections require close follow-up as surgical intervention may be necessary after initial presentation As above 7 to 14 days Your ID team is happy to answer questions M-F (and off hours if you are kind) David Graham, MD: zipit or (text if able) Jeff Jansen, PharmD: zipit or (call or text) 13
14 Procalcitonin will be available starting July 6 th from the lab. It is elevated in bacterial infections but not viral infections. It does not take the place of lactates for CMS sepsis protocol. In addition, if a patient meets sepsis critearia for CMS purposes, they will still need broad spectrum antibiotics even if they have a negative procalcitonin. 14
15 Additional Stewardship Implementations: 2017 Hiring of an infectious diseases trained pharmacist was completed in 03/2017 with start date of 07/2017 Initial steps towards regionalization through providing infectious diseases services to Holy Rosary Healthcare (Prospective review of HRH antimicrobial use on Tuesdays and Fridays). Infectious diseases E-consultations are also now available Empiric antimicrobial recommendations provided to emergency room physicians and pharmacist Daily prospective audits of patients on antimicrobial therapy for appropriateness of use Intensive care unit antimicrobial utilization recommendations. Infectious diseases pharmacist provides daily (weekdays) stewardship recommendations to ICU pharmacist and physically rounds with multidisciplinary team twice weekly (Monday and Thursday) Focused discussion to individual provider groups to improve patient care and decrease costs to both the health system and the patient Monthly reporting of stewardship outcomes to NHSN and local pharmacy and therapeutics committee Incidence of hospital acquired Clostridium difficile infections decreased by 60% in 2017 compared to Antimicrobial Stewardship Goals: 2018 Provide education and recommendations for standardized best clinical practices to outpatient providers and clinic personnel for antimicrobial stewardship in at least 3 of the following: o Sinusitis o o Bronchitis o o Community Acquired Pneumonia Pharyngitis Urinary Tract Infections Decrease Hospital-Wide antimicrobial utilization by 10% as determined by days of therapy per 1000 patient days as compared to 2017 Decrease Hospital-Wide carbapenem utilization by 20% as determined by days of therapy per 1000 patient days as compared to 2017 Decrease Intensive Care Unit antimicrobial utilization by 20% as determined by days of therapy per 1000 patient days as compared to 2017 Decrease Holy Rosary Hospital-Wide antimicrobial utilization by 10% as determined by days of therapy per 1000 patient days as compared to 2017 Maintain or improve hospital acquired Clostridium difficile rates as compared to 2017 Summary Overall, antimicrobial use at Saint Vincent decreased in This decrease was largely driven by a dramatic decrease in ICU antibiotic utilization. An increase in antimicrobial use was observed in 12/2017 (and continued in 01/2018). This is observed on an annual basis and is most likely partially associated with influenza season. Since the program informally began in 2015, total antibiotic use is down 33% while vancomycin use is down 61% and anti-pseudomonal use dropped 56%. Utilizing conservative numbers, our antimicrobial stewardship interventions either saved, prevented, or avoided ~$617,000 in 2017 which aligns with the published range of $200,000 to $900,000 by the Infectious Diseases Society of America (Clin Infec Dis 2007;44:159-77). 15
16 How do you get leadership buy in? Build it and they will come What resources do you already have available to work with? Don t ask for money or time. Do it and show how much money you are saving them. Then get a 30% raise 16
17 How do you get physician support? More important than leadership support Who can be your champion? Remember, they were trained in areas where broad spectrum empiricism probably made sense and where LESS THAN 1% of their TRAINING WAS DEVOTED TO ID YOU can be the expert 17
18 Projects Vanco Vanco/Zosyn Any antipsuedomonal for community processes (including diabetic foot!) PCN allergy No FQ use Procalcitonin Zosyn (piperacillin/tazobactam) 18
19 Live with the fear The first time is scary: HCAP with ceftriaxone/azithro Aspiration pneumonia with ceftriaxone alone Diabetic foot with ceftriaxone Stop the vanco in the am for simple cellulitis Challenge a true penicillin allergy with Cefs De-escalate right out of the ICU to community antibiotics 19
Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV
Empiric Antibiotics for Pediatric Infections Seen in ED NOTE: Choice of empiric antibiotic therapy must take into account local pathogen frequency and resistance patterns, individual patient characteristics,
More informationAntimicrobial Stewardship Programs The Same, but Different. Sara Nausheen, MD Kevin Kern, PharmD
Antimicrobial Stewardship Programs The Same, but Different Sara Nausheen, MD Kevin Kern, PharmD Antimicrobial Stewardship Programs The Same, but Different Objectives: Outline the overall function of an
More informationAntimicrobial Stewardship in the Long Term Care and Outpatient Settings. Carlos Reyes Sacin, MD, AAHIVS
Antimicrobial Stewardship in the Long Term Care and Outpatient Settings Carlos Reyes Sacin, MD, AAHIVS Disclosure Speaker and consultant in HIV medicine for Gilead and Jansen Pharmaceuticals Objectives
More informationRational management of community acquired infections
Rational management of community acquired infections Dr Tanu Singhal MD, MSc Consultant Pediatrics and Infectious Disease Kokilaben Dhirubhai Ambani Hospital, Mumbai Why is rational management needed?
More informationAntibiotic Stewardship Program (ASP) CHRISTUS SETX
Antibiotic Stewardship Program (ASP) CHRISTUS SETX Program Goals I. Judicious use of antibiotics Decrease use of broad spectrum antibiotics and deescalate use based on clinical symptoms Therapeutic duplication:
More informationAppropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases
Appropriate Management of Common Pediatric Infections Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases It s all about the microorganism The common pathogens Viruses
More informationAntibiotic Abyss. Discussion Points. MRSA Treatment Guidelines
Antibiotic Abyss Fredrick M. Abrahamian, D.O., FACEP, FIDSA Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical Center Sylmar, California
More information10/13/14. Low: not well absorbed. Good: [blood and tissue] < than if given IV. High: > 90% absorption orally
Low: not well absorbed PO agent not for serious infection nitrofurantoin Good: [blood and tissue] < than if given IV [Therapeutic] in excess of [effective] eg. cephalexin High: > 90% absorption orally
More informationAntibiotic Updates: Part II
Antibiotic Updates: Part II Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures
More informationBest Practices: Goals of Antimicrobial Stewardship
Best Practices: Goals of Antimicrobial Stewardship Gail Scully, M.D, M.P.H. and Elizabeth Radigan, PharmD, BCPS UMass Memorial Medical Center Division of Infectious Disease Department of Medicine September
More informationObjectives 4/26/2017. Co-Investigators Sadie Giuliani, PharmD, BCPS Claude Tonnerre, MD Jayme Hartzell, PharmD, MS, BCPS
IMPLEMENTATION AND ASSESSMENT OF A GUIDELINE-BASED TREATMENT ALGORITHM FOR COMMUNITY-ACQUIRED PNEUMONIA (CAP) Lucas Schonsberg, PharmD PGY-1 Pharmacy Practice Resident Providence St. Patrick Hospital Missoula,
More informationAntimicrobial Stewardship Program
Antimicrobial Stewardship Program David R. Woodard, MSc, FSHEA, CIC CDC: Antibiotic Resistance Threats in the United States, 2013 http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ CDC Threat Levels
More informationAntimicrobial Stewardship: The Premier Health Experience
Antimicrobial Stewardship: The Premier Health Experience Steve Burdette, MD, FIDSA Professor of Medicine Wright State University Boonshoft School of Medicine Director of Antimicrobial Stewardship Miami
More informationAntibiotic stewardship in long term care
Antibiotic stewardship in long term care Shira Doron, MD Associate Professor of Medicine Division of Geographic Medicine and Infectious Diseases Tufts Medical Center Boston, MA Consultant to Massachusetts
More informationAntimicrobial Stewardship
Antimicrobial Stewardship Background Why Antimicrobial Stewardship 30-50% of antibiotic use in hospitals are unnecessary or inappropriate Appropriate antimicrobial use is a medication-safety and patient-safety
More information1. List three activities pharmacists can implement to support. 2. Identify potential barriers to implementing antimicrobial
OPTIMIZING ANTIMICROBIAL STEWARDSHIP: IT STARTS IN THE EMERGENCY DEPARTMENT! 1 2 Objectives 1. List three activities pharmacists can implement to support health-system antimicrobial stewardship programs
More informationAntimicrobial Stewardship 101
Antimicrobial Stewardship 101 Betty P. Lee, Pharm.D. Pediatric Infectious Disease/Antimicrobial Stewardship Pharmacist Lucile Packard Children s Hospital Stanford Disclosure I have no actual or potential
More information11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose
Antimicrobial Stewardship Update 2016 APIC-CI Conference November 17 th, 2016 Jay R. McDonald, MD Chief, ID Section VA St. Louis Health Care System Assistant Professor of medicine Washington University
More information8/17/2016 ABOUT US REDUCTION OF CLOSTRIDIUM DIFFICILE THROUGH THE USE OF AN ANTIMICROBIAL STEWARDSHIP PROGRAM
Mary Moore, MS CIC MT (ASCP) Infection Prevention Coordinator Great River Medical Center, West Burlington REDUCTION OF CLOSTRIDIUM DIFFICILE THROUGH THE USE OF AN ANTIMICROBIAL STEWARDSHIP PROGRAM ABOUT
More informationProvincial Drugs & Therapeutics Committee Memorandum Version 2
Provincial Drugs & Therapeutics Committee Memorandum Version 2 16 Garfield Street 16, rue Garfield PO Box 2000, Charlottetown C.P. 2000, Charlottetown Prince Edward Island Île-du-Prince-Édouard Canada
More informationHealth PEI: Provincial Antibiotic Advisory Team Empiric Antibiotic Treatment Guidelines for Sepsis Syndromes in Adults
Health PEI: Provincial Antibiotic Advisory Team Empiric Antibiotic Treatment Guidelines for Sepsis Syndromes in Adults COMMUNITY-ACQUIRED PNEUMONIA HEALTHCARE-ASSOCIATED PNEUMONIA INTRA-ABDOMINAL INFECTION
More informationIMPLEMENTATION AND ASSESSMENT OF A GUIDELINE-BASED TREATMENT ALGORITHM FOR COMMUNITY-ACQUIRED PNEUMONIA (CAP)
IMPLEMENTATION AND ASSESSMENT OF A GUIDELINE-BASED TREATMENT ALGORITHM FOR COMMUNITY-ACQUIRED PNEUMONIA (CAP) Lucas Schonsberg, PharmD PGY-1 Pharmacy Practice Resident Providence St. Patrick Hospital Missoula,
More informationMHA/OHA HIIN Antibiotic Stewardship/MDRO Collaborative
MHA/OHA HIIN Antibiotic Stewardship/MDRO Collaborative Place picture here Nov. 14, 2017 Reminders For best sound quality, dial in at 1-800-791-2345 and enter code 11076 Please use the chat box to ask questions!
More informationHead to Toe: Common infections in Hospital settings. Katya Calvo MD Medical Director of Antimicrobial Stewardship Division of Infectious Diseases
Head to Toe: Common infections in Hospital settings Katya Calvo MD Medical Director of Antimicrobial Stewardship Division of Infectious Diseases Objectives To identify at least one common infection in
More informationAntimicrobial Stewardship in Ambulatory Care
Antimicrobial Stewardship in Ambulatory Care Nila Suntharam, M.D. May 5, 2017 Dr. Suntharam indicated no potential conflict of interest to this presentation. She does not intend to discuss any unapproved/investigative
More informationAdvanced Practice Education Associates. Antibiotics
Advanced Practice Education Associates Antibiotics Overview Difference between Gram Positive(+), Gram Negative(-) organisms Beta lactam ring, allergies Antimicrobial Spectra of Antibiotic Classes 78 Copyright
More informationAntimicrobial Stewardship:
Antimicrobial Stewardship: Inpatient and Outpatient Elements Angela Perhac, PharmD afperhac@carilionclinic.org Disclosure I have no relevant finances to disclose. Objectives Review the core elements of
More informationPrinciples of Infectious Disease. Dr. Ezra Levy CSUHS PA Program
Principles of Infectious Disease Dr. Ezra Levy CSUHS PA Program I. Microbiology (1) morphology (e.g., cocci, bacilli) (2) growth characteristics (e.g., aerobic vs anaerobic) (3) other qualities (e.g.,
More information6/15/2017 PART 1: THE PROBLEM. Objectives. What is Antimicrobial Resistance? Conflicts of Interest Disclosure Statement
Conflicts of Interest Disclosure Statement Getting a grasp on Antibiotic Use and Resistance: Principles of Antimicrobial Stewardship Speaker has nothing to disclose. Jacob M Kesner, PharmD UNMH PGY-2 Infectious
More information21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review
(1) Have all important studies/evidence of which you are aware been included in the application? Yes No Please provide brief comments on any relevant studies that have not been included: (2) For each of
More informationOptimizing Antimicrobial Stewardship Activities Based on Institutional Resources
Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources Andrew Hunter, PharmD, BCPS Infectious Diseases Clinical Pharmacy Specialist Michael E. DeBakey VA Medical Center Andrew.hunter@va.gov
More informationAntibiotic Stewardship at MetroWest Medical Center. Colleen Grocer, RPh, BCOP Co-Chair, Antibiotic Stewardship Committee
Antibiotic Stewardship at MetroWest Medical Center Colleen Grocer, RPh, BCOP Co-Chair, Antibiotic Stewardship Committee Antibiotic Stewardship Committee Subcommittee of Pharmacy and Therapeutics. Also
More informationApproach to pediatric Antibiotics
Approach to pediatric Antibiotics Gassem Gohal FAAP FRCPC Assistant professor of Pediatrics objectives To be familiar with common pediatric antibiotics o Classification o Action o Adverse effect To discus
More informationHost, Syndrome, Bug, Drug: Introducing 2 Frameworks to Approach Infectious Diseases Cases with an Antimicrobial Stewardship Focus
Host, Syndrome, Bug, Drug: Introducing 2 Frameworks to Approach Infectious Diseases Cases with an Antimicrobial Stewardship Focus Montana ACP Meeting 2018 September 8, 2018 Staci Lee, MD, MEHP Billings
More informationWENDY WILLIAMS, MT(AMT) MSAH DIRECTOR LABORATORY AND PATHOLOGY SERVICES. Appalachian Regional Healthcare System apprhs.org
Incorporating Automation and Rapid Diagnostic Technologies into the Micro Lab's Lean Workflow to Boost Productivity, Shorten Length of Stay, and Improve Antibiotic Utilization WENDY WILLIAMS, MT(AMT) MSAH
More informationInfectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles
Infectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles Conflicts of Interest None at this time May be discussing off-label indications KALIN M. CLIFFORD, PHARM.D., BCPS,
More informationUPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM
UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM Diane Rhee, Pharm.D. Associate Professor of Pharmacy Practice Roseman University of Health Sciences Chair, Valley Health
More informationPharmacist-Driven ASP. Jessica Holt, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Coordinator October 24 th, 2013
Pharmacist-Driven ASP Jessica Holt, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Coordinator October 24 th, 2013 Abbott Northwestern Hospital Largest not-for-profit hospital in the Twin Cities area
More informationThe Rise of Antibiotic Resistance: Is It Too Late?
The Rise of Antibiotic Resistance: Is It Too Late? Paul D. Holtom, MD Professor of Medicine and Orthopaedics USC Keck School of Medicine None DISCLOSURES THE PROBLEM Antibiotic resistance is one of the
More information11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1
Disclosures Selecting Antimicrobials for Common Infections in Children FMR-Contemporary Pediatrics 11/2016 Sean McTigue, MD Assistant Professor of Pediatrics, Pediatric Infectious Diseases Medical Director
More informationSepsis Wave II. Balancing Antibiotics Stewardship with Sepsis
Sepsis Wave II Balancing Antibiotics Stewardship with Sepsis Presenters Jessica Whittle, Phd, MD Lauren Epstein, MD, MSc Antibiotics. Easy. Jessica Whittle, MD, PhD, FACEP Research Director, Department
More informationASCENSION TEXAS Antimicrobial Stewardship: Practical Implementation Strategies
ASCENSION TEXAS Antimicrobial Stewardship: Practical Implementation Strategies Theresa Jaso, PharmD, BCPS (AQ-ID) Network Clinical Pharmacy Specialist Infectious Diseases Seton Healthcare Family Ascension
More informationNorthwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16
Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16 These criteria are based on national and local susceptibility data as well as Infectious Disease Society of America
More informationPharmacist Coordinated Antimicrobial Therapy: OPAT and Transitions of Care
Pharmacist Coordinated Antimicrobial Therapy: OPAT and Transitions of Care Jennifer McCann, PharmD, BCCCP State Director of Clinical Pharmacy Services St. Vincent Health Indiana Conflicts of Interest No
More informationReady to Launch: Antimicrobial Stewardship for All!
Ready to Launch: Antimicrobial Stewardship for All! Lucas Schulz, PharmD, BCPS AQ ID Clinical Coordinator Infectious Diseases PGY2 Infectious Diseases Residency Program Director Disclosures Consultant
More informationAntimicrobial Stewardship
Antimicrobial Stewardship Antimicrobial Stewardship Studies have estimated that 30 50% of antibiotics prescribed in acutecare hospitals are unnecessary or inappropriate 1 Antimicrobial stewardship definition:
More informationAntimicrobial Stewardship Program 2 nd Quarter
Antimicrobial Stewardship Program 2 nd Quarter May 19, 2016 Jill Hanson, WHA DeAnn Richards, MetaStar Objectives for Today Hospital Highlight UnityPoint Health - Meriter Status of the state Update on pilot
More informationUpdate on Fluoroquinolones. Charles Krasner, M.D. June 16, 2016 Antibiotic Stewardship Program -ECHO
Update on Fluoroquinolones Charles Krasner, M.D. June 16, 2016 Antibiotic Stewardship Program -ECHO Potential fluoroquinolone side-effects Increased risk, greater than with most other antibiotics, for
More informationCommonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities
Commonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities Introduction As the problem of antibiotic resistance continues to worsen in all healthcare setting, we
More informationClinical Practice Standard
Clinical Practice Standard 1-20-6-1-010 TITLE: INTRAVENOUS TO ORAL CONVERSION FOR ANTIMICROBIALS A printed copy of this document may not reflect the current, electronic version on OurNH. APPLICABILITY:
More informationThe Three R s Rethink..Reduce..Rocephin
The Three R s Rethink..Reduce..Rocephin By: Alisa Cuff RN,BN,CIC and John Bautista B.Sc. (Chem), B.Sc.Pharm, M.Sc.Pharm IPAC National Conference 2017 Newfoundland and Labrador Regional Health Authorities
More informationPIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS
PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS The current supply of piperacillin- tazobactam should be reserved f Microbiology / Infectious Diseases approval and f neutropenic sepsis, severe sepsis
More informationPreserve the Power of Antibiotics
PROVIDERInsight News for providers in Northeast Nebraska April 2016 Preserve the Power of Antibiotics Antimicrobial stewardship interventions have been proven to improve individual patient outcomes, reduce
More information4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES
CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA BILLIE BARTEL, PHARMD, BCCCP APRIL 7 TH, 2017 DISCLOSURE I have had no financial relationship over the past 12 months with any commercial
More informationANTIBIOTICS IN THE ER:
ANTIBIOTICS IN THE ER: EXPLORING THE ROLE OF ANTIMICROBIAL STEWARDSHIP IN THE EMERGENCY DEPARTMENT ANGELINA DAVIS, PHARMD, MS, BCPS (AQ-ID) LIAISON CLINICAL PHARMACIST DUKE ANTIMICROBIAL STEWARDSHIP OUTREACH
More informationInfectious Disease Update 2017
Infectious Disease Update 2017 Greg Moran, MD, FACEP, FIDSA Professor of Clinical Emergency Medicine Geffen School of Medicine at UCLA Dept. of Emergency Medicine and Division of Infectious Diseases Olive
More informationPresenter: Marc Meyer, BPharm, RPh, CIC, FAPIC Clinical Pharmacists, Infection Preventionist, Antibiotic Stewardship Pharmacist Southwest Health
Presenter: Marc Meyer, BPharm, RPh, CIC, FAPIC Clinical Pharmacists, Infection Preventionist, Antibiotic Stewardship Pharmacist Southwest Health System, Cortez, Colorado None How do AU vendors and NHSN
More informationInteractive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe
Interactive session: adapting to antibiogram Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe Case 1 63 y old woman Dx: urosepsis? After 2 d: intermediate result: Gram-negative bacilli Empiric antibiotic
More informationIDENTIFICATION: PROCESS: Waging the War against C. difficile Radical Multidisciplinary Approaches From a Community Hospital
Waging the War against C. difficile Radical Multidisciplinary Approaches From a Community Hospital Organization Name: St. Joseph Medical Center Type: Acute Care Hospital Contact Person: Leigh Chapman RN,
More information** the doctor start the lecture with revising some information from the last one:
Page 1 of 7 ** the doctor start the lecture with revising some information from the last one: #penicillin G has a good susceptibility against gram(+ve), Neisseria (-ve) #mostly active against strep. (don
More informationMercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016
Mercy Medical Center Des Moines, Iowa Department of Pathology Microbiology Department Antibiotic Susceptibility January December 2016 These statistics are intended solely as a GUIDE to choosing appropriate
More informationPrescribing Guidelines for Outpatient Antimicrobials in Otherwise Healthy Children
Prescribing Guidelines for Outpatient Antimicrobials in Otherwise Healthy Children Prescribing Antimicrobials for Common Illnesses When treating common illnesses such as ear infections and strep throat,
More informationFelipe N. Gutierrez MD, MPH Chief, Infectious Diseases Phoenix VA Healthcare
Felipe N. Gutierrez MD, MPH Chief, Infectious Diseases Phoenix VA Healthcare 100% of all wounds will yield growth If you get a negative culture you something is wrong! Pseudomonas while ubiquitous does
More informationObjectives. Review basic categories of intra-abdominal infection and their respective treatments. Community acquired intra-abdominal infection
Objectives Review basic categories of intra-abdominal infection and their respective treatments Community acquired intra-abdominal infection Mild/Moderate Severe Acute biliary tract infections Nosocomial
More informationPRMCE ANTI-INFECTIVES SELECTION GUIDELINE FOR ADULTS (Revision October 22, 2015)
PRMCE ANTI-INFECTIVES SELECTION GUIDELINE FOR ADULTS (Revision October 22, 2015) SKIN AND SOFT TISSUE INFECTIONS: Mild A. Cellulitis: MRSA uncommonly causes cellulitis in the absence of a wound or abscess.
More informationInappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012
Inappropriate Use of Antibiotics and Clostridium difficile Infection Jocelyn Srigley, MD, FRCPC November 1, 2012 Financial Disclosures } No conflicts of interest } The study was supported by a Hamilton
More informationDisclosures. Principles of Antimicrobial Therapy. Obtaining an Accurate Diagnosis Obtain specimens PRIOR to initiating antimicrobials
Disclosures Principles of Antimicrobial Therapy None Lori A. Cox MSN, ACNP-BC, ACNPC, FCCM Penn State Hershey Medical Center Neuroscience Critical Care Unit Obtaining an Accurate Diagnosis Determine site
More informationAntibiotic Stewardship Beyond Hospital Walls
Antibiotic Stewardship Beyond Hospital Walls Katie Burenheide Foster, PharmD, MS, BCPS, FCCM Pharmacy Clinical Manager & PGY1 Pharmacy Residency Director OBJECTIVES 1. Review what Antibiotic Stewardship
More informationAn Approach to Appropriate Antibiotic Prescribing in Outpatient and LTC Settings?
An Approach to Appropriate Antibiotic Prescribing in Outpatient and LTC Settings? Dr. Andrew Morris Antimicrobial Stewardship ProgramMt. Sinai Hospital University Health Network amorris@mtsinai.on.ca andrew.morris@uhn.ca
More informationDiscussion Points. Decisions in Selecting Antibiotics
Antibiotics in Acute Care Fredrick M. Abrahamian, D.O., FACEP, FIDSA Clinical Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical
More informationLet me clear my throat: empiric antibiotics in
Let me clear my throat: empiric antibiotics in respiratory tract infections Alexander John Langley, MD MS MPH Goals of this talk Overuse of antibiotics is a major issue, as a result many specialist medical
More informationAntibiotics: Selected Topics Steven Park, MD/PhD Director, Antimicrobial Stewardship Program Division of Infectious Diseases UCI Medical Center
Antibiotics: Selected Topics Steven Park, MD/PhD Director, Antimicrobial Stewardship Program Division of Infectious Diseases UCI Medical Center Case 1 60 yo healthy female admitted for fevers and dysuria.
More information* gender factor (male=1, female=0.85)
Usual Doses of Antimicrobials Typically Not Requiring Renal Adjustment Azithromycin 250 500 mg Q24 *Amphotericin B 1 3-5 mg/kg Q24 Clindamycin 600 900 mg Q8 Liposomal (Ambisome ) Doxycycline 100 mg Q12
More informationAntibiotic Stewardship
Antibiotic Stewardship Nick Zaksek Pharm D., BCPS AQ-ID Infectious Disease POMA 2019 1 Disclosures None 2 Objectives Practice good Antibiotic stewardship and foster the notion of antibiotic stewardship
More informationMisericordia Community Hospital (MCH) Antimicrobial Stewardship Report. July December 2013 Second and Third Quarters 2014
H e a l i n g t h e B o d y E n r i c h i n g t h e M i n d N u r t u r i n g t h e S o u l Misericordia Community Hospital (MCH) Antimicrobial Stewardship Report July December 213 Second and Third Quarters
More informationAntimicrobial Stewardship
Antimicrobial Stewardship Report: 11 th August 2016 Issue: As part of ensuring compliance with the National Safety and Quality Health Service Standards (NSQHS), Yea & District Memorial Hospital is required
More informationGeriatric Mental Health Partnership
Geriatric Mental Health Partnership September 8, 2017 First, let s test your knowledge about antibiotics http://www.cdc.gov/getsmart/community/about/quiz.html 2 Get Smart Antibiotics Quiz Antibiotics fight
More informationCLINICAL USE OF BETA-LACTAMS
CLINICAL USE OF BETA-LACTAMS Douglas Black, Pharm.D. Associate Professor School of Pharmacy University of Washington dblack@u.washington.edu WHY IS INFECTIOUS DISEASE PHARMACOTHERAPY SO CONFUSING? Microbial
More informationHigh Risk Emergency Medicine. Antibiotic Pitfalls
High Risk Emergency Medicine Antibiotic Pitfalls David, MD MS Assistant Professor Department of Emergency Medicine University of California, San Francisco I. Antibiotic Resistance Development of resistance
More informationnumber Done by Corrected by Doctor Dr.Malik
number 27 Done by Fatimah Farhan Corrected by Basil Al-Bakri Doctor Dr.Malik Note: anything in red is just extra info and you will not be asked about it in the exam. In this sheet we will continue talking
More information3/20/2011. Code 215 of Hammurabi: If a physician performed a major operation on
The Good Antibiotics: the Good, the Bad and the Ugly John P. Cello, MD Professor of Medicine and Surgery, University of California, San Francisco Most organisms can be readily identified by culture, special
More informationCommunity-Associated C. difficile Infection: Think Outside the Hospital. Maria Bye, MPH Epidemiologist May 1, 2018
Community-Associated C. difficile Infection: Think Outside the Hospital Maria Bye, MPH Epidemiologist Maria.Bye@state.mn.us 651-201-4085 May 1, 2018 Clostridium difficile Clostridium difficile Clostridium
More informationIncidence of hospital-acquired Clostridium difficile infection in patients at risk
Baptist Health South Florida Scholarly Commons @ Baptist Health South Florida All Publications 5-20-2016 Incidence of hospital-acquired Clostridium difficile infection in patients at risk Christine Ibarra
More informationToday s webinar will begin in a few minutes.
Today s webinar will begin in a few minutes. Please press *6 to mute your line or use the mute button on your phone. If you have questions for the presenter or need to contact TCPS staff, type your comments
More informationOBJECTIVES. Fast Facts 3/23/2017. Antibiotic Stewardship Beyond Hospital Walls. Antibiotics are a shared resource and becoming a scarce resource.
Antibiotic Stewardship Beyond Hospital Walls Katie Burenheide Foster, PharmD, MS, BCPS, FCCM Pharmacy Clinical Manager & PGY1 Pharmacy Residency Director OBJECTIVES 1. Review what Antibiotic Stewardship
More informationAntibiotic Updates: Part I
Antibiotic Updates: Part I Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures
More informationGhinwa Dumyati, MD Christina Felsen, MPH University of Rochester Medical Center
Ghinwa Dumyati, MD Christina Felsen, MPH University of Rochester Medical Center How do you decide where to start? Start small; core elements recommend you focus on one thing at a time Use data to help
More informationNecrotizing Soft Tissue Infections: Emerging Bacterial Resistance
Necrotizing Soft Tissue Infections: Emerging Bacterial Resistance Eileen M. Bulger, MD Professor of Surgery Harborview Medical Center University of Washington Objectives Review definition & diagnostic
More information3/23/2017. Kathryn G. Smith, PharmD PGY1 Pharmacy Resident Via Christi Hospitals Wichita, Inc. Kathryn G. Smith: Nothing to disclose
Kathryn G. Smith, PharmD PGY1 Pharmacy Resident Via Christi Hospitals Wichita, Inc Kathryn G. Smith: Nothing to disclose Describe the new updates and rationale for them Relay safety concerns with use of
More informationANTIMICROBIAL STEWARDSHIP IN LONG TERM CARE FACILITIES
ANTIMICROBIAL STEWARDSHIP IN LONG TERM CARE FACILITIES ANTIMICROBIAL STEWARDSHIP COLLABORATIVE COLORADO HOSPITAL ASSOCIATION MARCH 23, 2016 Bridget Olson, RPh Infectious Disease Pharmacist, Sharp Coronado
More informationGeneral Approach to Infectious Diseases
General Approach to Infectious Diseases 2 The pharmacotherapy of infectious diseases is unique. To treat most diseases with drugs, we give drugs that have some desired pharmacologic action at some receptor
More informationAntibiotic Stewardship in the LTC Setting
Antibiotic Stewardship in the LTC Setting Joe Litsey, Director of Consulting Services Pharm.D., Board Certified Geriatric Pharmacist Thrifty White Pharmacy Objectives Describe the Antibiotic Stewardship
More informationGrey Nuns Community Hospital (GNCH) Antimicrobial Stewardship Report
H e a l i n g t h e B o d y E n r i c h i n g t h e M i n d N u r t u r i n g t h e S o u l Grey Nuns Community Hospital (GNCH) Antimicrobial Stewardship Report to 214 Table of Contents I. Introduction..
More informationANTIBIOTIC STEWARDSHIP. Brian Mayhue, Pharm D, CGP Director of Pharmacy Palm Beach Gardens Medical Center
ANTIBIOTIC STEWARDSHIP Brian Mayhue, Pharm D, CGP Director of Pharmacy Palm Beach Gardens Medical Center Antibiotic Resistance It is not difficult to make microbes resistant to penicillin in the laboratory
More informationDATA COLLECTION SECTION BY FRONTLINE TEAM. Patient Identifier/ Medical Record number (for facility use only)
Assessment of Appropriateness of ICU Antibiotics (Patient Level Sheet) **Note this is intended for internal purposes only. Please do not return to PQC.** For this assessment, inappropriate antibiotic use
More informationAntimicrobial Stewardship: Stopping the Spread of Antibiotic Resistance
Antimicrobial Stewardship: Stopping the Spread of Antibiotic Resistance Natalie Weber, PharmD PGY2 Critical Care Pharmacy Resident September 22, 2016 The speaker has no actual or potential conflicts of
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIX NUMBER 3 November 2014 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Marti Roe SM MLS (ASCP), Sarah Parker MD, Jason Child PharmD, and Samuel R.
More informationObjective 1/20/2016. Expanding Antimicrobial Stewardship into the Outpatient Setting. Disclosure Statement of Financial Interest
Expanding Antimicrobial Stewardship into the Outpatient Setting Michael E. Klepser, Pharm.D., FCCP Professor Pharmacy Practice Ferris State University College of Pharmacy Disclosure Statement of Financial
More informationGive the Right Antibiotics in Trauma Mitchell J Daley, PharmD, BCPS
Give the Right Antibiotics in Trauma Mitchell J Daley, PharmD, BCPS Clinical Pharmacy Specialist, Critical Care Dell Seton Medical Center at the University of Texas and Seton Healthcare Family Clinical
More informationMisericordia Community Hospital (MCH) Antimicrobial Stewardship Report
Misericordia Community Hospital (MCH) Antimicrobial Stewardship Report July December 216 Table of Contents I. Introduction... 3 II. Executive Summary... 5 III. MCH Antimicrobial Utilization Reports...
More information